News

PDS Biotechnology halts PDS0101 trial in head and neck cancer to redirect resources toward PDS0301 development in colorectal cancer.

Sionna's SION-719 fails to meet sweat chloride target in Phase 2a CF study of patients already on Trikafta therapy.

Oncoinvent publishes dosimetry data for Radspherin showing normal organ doses below complication thresholds in peritoneal metastases patients.

Tenax announces Phase 3 LEVEL Trial topline results for TNX-103 in pulmonary hypertension with heart failure, a challenging indication...

Kodiak Sciences enrolls first patient in Phase 3 ALTO trial of KSI-501, testing dual IL-6 and VEGF blockade in...

FDA clears IND for circular RNA CAR-T therapy RXIM002, enabling subcutaneous dosing and accelerated Phase 1 trial design for...

David Sinclair launches Lifespan media platform to improve public understanding of longevity science research and clinical trials.

FDA authorizes CLiK Extra for New World screwworm prevention in livestock, marking the third EUA-backed tool in the U.S....

CytoSorbents pursues FDA De Novo classification for DrugSorb-ATR to address perioperative bleeding in cardiac surgery patients.

Theriva Biologics doses first patient in VIRAGE2 trial of VCN-01 for metastatic pancreatic cancer, testing increased dosing frequency with...